Prognostic value of Osteopontin (SPP1) in colorectal carcinoma requires a personalized molecular approach
Stratification of colorectal cancer for better management and tangible clinical outcomes is lacking in clinical practice. To reach this goal, the identification of reliable biomarker(s) is a prerequisite to deliver personalized colorectal cancer theranostics. Osteopontin (SPP1) is a key extracellula...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IOS Press
2019-09-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428319863627 |